Impact of Evolocumab on Coronary Physiology on JHLT: The Podcast
This week on JHLT: The Podcast, the Digital Media team returns with an episode discussing the paper, “Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipients,” from the January issue of JHLT.
Featured on this episode is early career guest host Bin Yang, MD, of Massachusetts General Hospital. Mentored by Digital Media Editor Van-Khue Ton, MD, PhD, Dr. Yang shares hosting duties this episode and brings great questions to the discussion.
Drs. Yang and Ton are joined by the first author, Salma Karim, and senior author, Hans Eiskjær, both from Aarhus University Hospital in Denmark.
Listen Now
You can also stream the podcast on Spotify, Amazon, iTunes, and anywhere else you get podcasts.
The discussion explores:
- What imaging and physical markers the researchers used to determine if evolocumab was influencing the development of cardiac allograft vasculopathy (CAV)
- The potential role of lipid-lowering therapies or statins in treating CAV
- The relationship between CAV and microvascular resistance (IMR)
For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you’re an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
In case you missed it, earlier this month the JHLT Digital Media Editors recapped their favorite papers from 2025. Take a listen and catch up on the manuscripts.
Don’t already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation for a free subscription, or subscribe today at www.jhltonline.org.
Listen Now
You can also stream the podcast on Spotify, Amazon, iTunes, and anywhere else you get podcasts.